When prospective patients call you, who returns their call — and how long does it take? Watch this short video about response time.
Last fall, we created a standardized brand identity and guidelines for clinical research and development communications for the HARMONEE Program from Adare Pharmaceuticals. Adare studies are underway with the goal of improving treatment for Eosinophilic esophagitis, including its novel orally disintegrating tablet (ODT) containing the active pharmaceutical ingredient fluticasone. Eosinophilic esophagitis (EoE) is a chronic immune-mediated disease characterized by presence of tissue eosinophilia and symptoms of esophageal dysfunction. To date, no medications have been FDA-approved to treat this condition. The use of these identity guidelines will ensure that the elements, relevance, and benefits of […]
The Ad Hoc Group for Medical Research published an ad in the Wall Street Journal and Politico on May 23, 2017, thanking Congress for its support of medical research and recommending continued progress in FY 2018. The Ad Hoc Group for Medical Research is a coalition of patient and voluntary health groups, medical and scientific societies, academic and research organizations, and industry that support enhancing the federal investment in the biomedical, behavioral, and population-based research conducted and supported by the NIH. More than 300 organizations and institutions across the NIH stakeholder community recommend $36.2 billion for NIH in FY 2018, including funds provided through […]
“Today’s medicines can cost hundreds of thousands of dollars a year. The story of how two companies set prices for their costly new drugs suggests that the way we determine the value of such treatments will help decide the future of our health-care system,” writes Barry Werth in the MIT Technology Review. In “A Tale of Two Drugs,”, he writes that the advent of these more targeted, more effective drugs will introduce the prospect of ever-rising prices, highly effective and ultra-expensive so-called orphan drugs like Kalydeco may impose a stricter rubric for determining the price of all […]
I’ve published a book with the full text of House version of The American Health Care Act of 2017 (H.R. 1628), along with the Senate’s proposed Better Care Reconciliation Act. It includes my introduction and commentary on key implications. In the debate around the health care law, it’s unclear how (or how soon) Congress will make modifications to resolve all their differences. Until then, we should all get informed on the most important proposed changes that would affect us. Repeal of “individual mandate” penalty on those without “adequate” health insurance coverage The Obamacare legislation imposed the so-called individual mandate, which is […]
Consider reading the full health care bill and letting your Senator know you’re an informed citizen. That’s why I was motivated to publish and share the full text of The American Health Care Act and now, a second edition updated with the Better Care Reconciliation Act. How Congress will resolve their differences, and how quickly, is unclear. But one things IS clear: the patients can’t wait – nor can the doctors, the hospitals, the insurers, and all of us as stakeholders in health care. Now on Amazon: https://www.amazon.com/AHCA-BCRA-Bills-Representatives-Reconciliation/dp/1548374873/ref=sr_1_1?s=books&ie=UTF8&qid=1498598140&sr=1-1&keywords=bcra